Post-earnings recap
Reported
Tue, Mar 25, 2025
EPS actual
$0.22
EPS est.
$0.17
EPS surprise
+29.41%
1-day move
-31.85%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a better-than-expected EPS for the quarter, but the stock dropped significantly by 31.85%. This decline may reflect investor concerns or broader market reactions, as no revenue figures were provided and no guidance was issued. The lack of detailed commentary from management may also have contributed to uncertainty among investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.22 | N/A | +29.41% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.